These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7488317)

  • 41. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carmoxirole inhibits platelet aggregation in vitro and ex vivo.
    Kirsten R; Breidert M; Sparwasser K; Ochs JG; Hesse K; Nelson K
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):76-80. PubMed ID: 7757314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of prostaglandin E1 on the formation of experimental arterial and venous thrombosis].
    Zimmermann R; Stadler J; Harenberg J; Kübler W
    Wien Klin Wochenschr; 1988 Jul; 100(14):481-4. PubMed ID: 3213054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnesium inhibits platelet activity--an in vitro study.
    Ravn HB; Vissinger H; Kristensen SD; Husted SE
    Thromb Haemost; 1996 Jul; 76(1):88-93. PubMed ID: 8819258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers.
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Massignon D; Calic F; Sibille M; Kirkesseli S
    J Clin Pharmacol; 2000 Nov; 40(11):1245-56. PubMed ID: 11075310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombotic activity of SR 46349, a novel, potent and selective 5-HT2 receptor antagonist.
    Herbert JM; Bernat A; Barthelemy G; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):262-7. PubMed ID: 8470049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats.
    Wakitani K; Takakuwa T; Sugioka M; Fujitani B; Aishita H
    Jpn J Pharmacol; 1992 May; 59(1):57-63. PubMed ID: 1507658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
    J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins.
    Fitscha P; Kaliman J; O'Grady J; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):443-6. PubMed ID: 2465949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous infusion of iloprost and prostaglandin E1 (PGE1): cardiovascular profile in anaesthetized rabbits.
    Müller B; Maass B; Stürzebecher S
    Prog Clin Biol Res; 1989; 301():401-5. PubMed ID: 2477856
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
    Holbrook M; Coker SJ
    Br J Pharmacol; 1989 Sep; 98(1):318-24. PubMed ID: 2478245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
    Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
    Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
    Belch JJ; McLaren M; Lau CS; Mackay IR; Bancroft A; McEwen J; Thompson JM
    Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of TFC-612, a 7-thia prostaglandin E1 derivative, on platelet function.
    Motoyama Y; Sakata Y; Seki J; Asada T; Namikawa Y; Horiai H; Ono T
    Thromb Res; 1991 Jul; 63(1):29-38. PubMed ID: 1658963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
    Kunihara M; Tsuchida K; Kaneko K; Suga H; Hasegawa T; Mochizuki S; Kawai K; Shiga A; Yamaguchi T
    Arzneimittelforschung; 2002; 52(5):358-64. PubMed ID: 12087920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.